1. Home
  2. RIGL vs CAN Comparison

RIGL vs CAN Comparison

Compare RIGL & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIGL
  • CAN
  • Stock Information
  • Founded
  • RIGL 1996
  • CAN 2013
  • Country
  • RIGL United States
  • CAN Singapore
  • Employees
  • RIGL N/A
  • CAN N/A
  • Industry
  • RIGL Biotechnology: Pharmaceutical Preparations
  • CAN Semiconductors
  • Sector
  • RIGL Health Care
  • CAN Technology
  • Exchange
  • RIGL Nasdaq
  • CAN Nasdaq
  • Market Cap
  • RIGL 335.5M
  • CAN 330.5M
  • IPO Year
  • RIGL 2000
  • CAN 2019
  • Fundamental
  • Price
  • RIGL $38.85
  • CAN $0.74
  • Analyst Decision
  • RIGL Buy
  • CAN Strong Buy
  • Analyst Count
  • RIGL 5
  • CAN 6
  • Target Price
  • RIGL $38.20
  • CAN $2.50
  • AVG Volume (30 Days)
  • RIGL 995.6K
  • CAN 32.6M
  • Earning Date
  • RIGL 08-05-2025
  • CAN 08-14-2025
  • Dividend Yield
  • RIGL N/A
  • CAN N/A
  • EPS Growth
  • RIGL N/A
  • CAN N/A
  • EPS
  • RIGL 5.43
  • CAN N/A
  • Revenue
  • RIGL $267,921,000.00
  • CAN $345,360,000.00
  • Revenue This Year
  • RIGL $59.93
  • CAN $90.25
  • Revenue Next Year
  • RIGL N/A
  • CAN $42.94
  • P/E Ratio
  • RIGL $7.15
  • CAN N/A
  • Revenue Growth
  • RIGL 105.62
  • CAN 82.40
  • 52 Week Low
  • RIGL $12.66
  • CAN $0.53
  • 52 Week High
  • RIGL $43.72
  • CAN $3.27
  • Technical
  • Relative Strength Index (RSI)
  • RIGL 68.57
  • CAN 51.63
  • Support Level
  • RIGL $39.00
  • CAN $0.64
  • Resistance Level
  • RIGL $42.08
  • CAN $0.80
  • Average True Range (ATR)
  • RIGL 2.32
  • CAN 0.05
  • MACD
  • RIGL -0.37
  • CAN 0.00
  • Stochastic Oscillator
  • RIGL 53.26
  • CAN 59.38

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

Share on Social Networks: